Vancomycin hydrochloride and Shock - a phase IV clinical study of FDA data

Summary:

Shock is reported as a side effect among people who take Vancomycin hydrochloride (vancomycin hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Meropenem, and have Acute leukaemia.

The phase IV clinical study analyzes which people have Shock when taking Vancomycin hydrochloride. It is created by eHealthMe based on reports of 8,214 people who have side effects when taking Vancomycin hydrochloride from the FDA, and is updated regularly.

What is Vancomycin hydrochloride?

Vancomycin hydrochloride has active ingredients of vancomycin hydrochloride. It is often used in mrsa infection. eHealthMe is studying from 8,399 Vancomycin hydrochloride users. Check the latest studies of Vancomycin hydrochloride.

What is Shock?

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin) is found to be associated with 1,213 drugs and 1,755 conditions by eHealthMe. Check the latest studies of Shock.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

8,214 people reported to have side effects when taking Vancomycin hydrochloride.
Among them, 62 people (0.75%) have Shock.

Could Vancomycin hydrochloride cause Shock?

Among these 62 people:

How long have people been on Vancomycin hydrochloride when they have Shock? *

  • < 1 month: 94.12 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 5.88 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Shock when taking Vancomycin hydrochloride? *

  • female: 54.72 %
  • male: 45.28 %

What is the age of people who have Shock when taking Vancomycin hydrochloride? *

  • 0-1: 2 %
  • 2-9: 4 %
  • 10-19: 4 %
  • 20-29: 4 %
  • 30-39: 2 %
  • 40-49: 10 %
  • 50-59: 26 %
  • 60+: 48 %

What are other drugs people take besides Vancomycin hydrochloride? *

  1. Meropenem: 15 people, 24.19%
  2. Omeprazole: 11 people, 17.74%
  3. Acyclovir: 7 people, 11.29%
  4. Solu-Medrol: 7 people, 11.29%
  5. Lasix: 7 people, 11.29%
  6. Vfend: 6 people, 9.68%
  7. Prograf: 6 people, 9.68%
  8. Maxipime: 6 people, 9.68%
  9. Ambisome: 5 people, 8.06%
  10. Ceftazidime: 5 people, 8.06%

What are other side effects people have besides Shock? *

  1. Drug Ineffective: 13 people, 20.97%
  2. Thrombocytopenia (decrease of platelets in blood): 13 people, 20.97%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 12 people, 19.35%
  4. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 10 people, 16.13%
  5. Acute Kidney Failure: 9 people, 14.52%
  6. Staphylococcal Infection (an infection with staphylococcus bacteria): 8 people, 12.90%
  7. Hypotension (abnormally low blood pressure): 7 people, 11.29%
  8. Cardiac Arrest: 7 people, 11.29%
  9. Renal Disorder (kidney disease): 7 people, 11.29%
  10. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 11.29%

What are the existing conditions these people have? *

  1. Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 6.45%
  2. Fungal Infection: 4 people, 6.45%
  3. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 6.45%
  4. Acute Leukaemia (blood cancer): 4 people, 6.45%
  5. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 4.84%
  6. Systemic Candida (whole body fungal infection): 3 people, 4.84%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 4.84%
  8. Pneumonia: 3 people, 4.84%
  9. Intraocular Pressure Decreased: 3 people, 4.84%
  10. Multiple Myeloma (cancer of the plasma cells): 3 people, 4.84%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin hydrochloride and have Shock?

- Check whether Shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vancomycin hydrochloride:

Shock treatments and more:

How severe was Shock and when was it recovered:

Expand to all the drugs that have ingredients of vancomycin hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vancomycin hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Shock:

Browse all the conditions that are associated with Shock:

  • Shock (1,755 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vancomycin hydrochloride (the active ingredients of Vancomycin hydrochloride) and Vancomycin hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: